The North America iodinated contrast media in interventional X-Ray market is expected to witness significant growth during the forecast period. According to the National Health Council records, in 2020, approximately 157 million people in the U.S. were affected by chronic diseases, out of which about 81 million had multiple conditions, which is indicative of a high occurrence of chronic conditions. Rising preference towards iodinated contrast media from traditional contrast media is boosting the market during the forecast period.
